Limosilactobacillus reuteri 6475 and Prevention of Early Postmenopausal Bone Loss: A Randomized Clinical Trial

医学 罗伊乳杆菌 安慰剂 骨量减少 骨质疏松症 骨矿物 N-末端末端肽 内科学 骨钙素 碱性磷酸酶 益生菌 细菌 替代医学 化学 酶 病理 生物 生物化学 遗传学
作者
Giulia Gregori,Aldina Pivodic,Per Magnusson,Lisa Johansson,Ulrika Hjertonsson,Emma Brättemark,Mattias Lorentzon
出处
期刊:JAMA network open [American Medical Association]
卷期号:7 (6): e2415455-e2415455 被引量:47
标识
DOI:10.1001/jamanetworkopen.2024.15455
摘要

Importance: Daily supplementation with the probiotic Limosilactobacillus reuteri ATCC PTA 6475 (L reuteri) vs placebo has previously been demonstrated to reduce bone loss in an estrogen deficiency mice model and older women, although the magnitude of the effect was small. We hypothesized that long-term treatment with L reuteri could result in clinically relevant skeletal benefits in postmenopausal osteoporosis. Objective: To evaluate whether daily supplementation with L reuteri vs placebo could reduce early postmenopausal bone loss and whether the effects remained or increased over time during 2 years of treatment. Design, Setting, and Participants: A double-blind, randomized, placebo-controlled clinical trial was conducted between December 4, 2019, and October 6, 2022, at a single center in Gothenburg, southwestern Sweden. Participants were recruited by online advertisements, and letters were sent to 10 062 women aged 50 to 60 years. Responding women (n = 752) underwent telephone screening, resulting in 292 women being invited to a screening visit. Of those who were screened, 239 women met all inclusion criteria and had no exclusion criteria. Interventions: Capsules with L reuteri in 2 doses, 5 × 108 (low dose) or 5 × 109 (high dose) colony-forming units, taken twice daily or placebo were administered. All capsules also included cholecalciferol, 200 IU. Main Outcomes and Measures: The primary outcome was the relative change in tibia total volumetric bone mineral density (vBMD) over 2 years. Secondary outcomes included relative change in areal BMD of the lumbar spine and total hip, bone turnover markers C-terminal telopeptide cross-links of collagen type I and type I procollagen intact N-terminal propeptide, as well as tibia trabecular bone volume fraction and cortical vBMD. Both intention-to-treat and per-protocol analyses were conducted. Results: A total of 239 postmenopausal women (median age, 55 [IQR, 53-56] years) were included. Tibia vBMD (primary outcome), hip and spine vBMD, and tibia cortical area and BMD decreased significantly in all groups, with no group-to-group differences (percent change tibia vBMD high dose vs placebo least-squares means, -0.08 [95 CI, -0.85 to 0.69] and low dose vs placebo least-squares means, -0.22 [95% CI, -0.99 to 0.55]). There were no significant treatment effects on any other predefined outcomes. A prespecified sensitivity analysis found a significant interaction between body mass index (BMI) and treatment effect at 2 years. No significant adverse effects were observed. Conclusions and Relevance: In this randomized clinical trial of 239 early postmenopausal women, supplementation with L reuteri had no effect on bone loss or bone turnover over 2 years. The observed interaction between BMI and treatment effect warrants further investigation. Trial Registration: ClinicalTrials.gov Identifier: NCT04169789.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
房子完成签到,获得积分10
刚刚
情怀的应助被机灵的听荷采纳,获得10
刚刚
fireulc发布了新的文献求助10
刚刚
田様的应助被优美的豪英采纳,获得10
刚刚
复杂的绮兰完成签到,获得积分10
1秒前
笑傲江湖完成签到,获得积分10
1秒前
1秒前
小芃完成签到,获得积分10
1秒前
xlp完成签到,获得积分10
1秒前
ccc完成签到 ,获得积分10
2秒前
Expelliarmus发布了新的文献求助10
2秒前
贝壳完成签到,获得积分10
3秒前
可燃乌龙茶完成签到 ,获得积分10
4秒前
4秒前
5秒前
房子发布了新的文献求助10
5秒前
worldpeace完成签到,获得积分10
6秒前
林林发布了新的文献求助10
6秒前
6秒前
嘻嘻哈哈的应助被云落采纳,获得10
6秒前
Akim的应助被hanxx采纳,获得10
7秒前
7秒前
华仔的应助被湖蓝色块采纳,获得10
7秒前
molihuakai的应助被斯文曼波采纳,获得10
8秒前
FFF完成签到,获得积分20
8秒前
dou完成签到 ,获得积分10
9秒前
风朝东发布了新的文献求助10
9秒前
充电宝的应助被呼呼采纳,获得10
9秒前
TFauthor发布了新的文献求助50
10秒前
小帅完成签到,获得积分10
10秒前
11秒前
dlsq发布了新的文献求助30
11秒前
sy发布了新的文献求助10
11秒前
ket的应助被本色风情采纳,获得10
11秒前
木木完成签到,获得积分10
12秒前
111发布了新的文献求助10
13秒前
14秒前
14秒前
15秒前
leizhengyu完成签到,获得积分10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187918
求助须知:如何正确求助?哪些是违规求助? 9575850
关于积分的说明 21843829
捐赠科研通 7785760
什么是DOI,文献DOI怎么找? 3435128
关于科研通互助平台的介绍 2559501
邀请新用户注册赠送积分活动 2482027